#Vietnam – Page 23 – HEALTHCARE INSIGHTS

Key Development Imexpharm Pharmaceutical Joint Stock Company (Ticker: IMP)—a premier listed pharmaceutical manufacturer on the Vietnamese equity markets—has officially released... Read more

Tag: #Vietnam

Enforcing Regional Safety Standards: Drug Administration of Vietnam Decrees Nationwide Recall of 4 Anti-Dandruff Shampoos Over Prohibited Fungal Inhibitor Clotrimazole

Manufacturing Compliance Enforcement: Drug Administration of Vietnam Decrees Nationwide Recall of Dr. Clean and Young Rau Ma Batches Over Formulation Discrepancies

Enforcing Regional Safety Standards: Drug Administration of Vietnam Decrees Nationwide Recall of 4 Anti-Dandruff Shampoos Containing Banned Ingredient Clotrimazole

Post-M&A Executive Realignment: China’s Livzon Group Assumes Control of Imexpharm (IMP), Directing a 6% Cash Dividend

Biopharma Technical Standardization: Ministry of Health Launches Vietnamese Pharmacopoeia VI to Revolutionize Quality Control Infrastructure

Manufacturing Compliance Enforcement: Drug Administration of Vietnam Orders Nationwide Recall of Hoa Xu Lang Herbal Hair Care Products

Manufacturing Calibration Deficits: Lam Dong Health Authorities Seal Ladophar’s Artichoke Drug Over Volume Discrepancy

Decentralizing High-Acute Care: Viet Duc Hospital’s Multimillion-Dollar Facility No. 2 Poised for Launch on July 10

Dominating the Chronic Care Matrix: Analyzing Viatris’ 5-Year Journey and Strategic Originator Localization in Vietnam

Facebook

Map

Online Members